atorvastatin has been researched along with Cytomegalovirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aman Nasution, S; Estiasari, R; Jasirwan, COM; Purnamasari, D; Rusdi, L; Shinta Noviar, M; Syahrir Azizi, M; Wulandari, EAT; Yunihastuti, E | 1 |
| Chan, KH; Chau, E; Lai, KC; Wai-Hung Shek, T; Wong, WM | 1 |
1 trial(s) available for atorvastatin and Cytomegalovirus Infections
| Article | Year |
|---|---|
Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial.
Topics: Atherosclerosis; Atorvastatin; Carotid Intima-Media Thickness; Cholesterol, LDL; Cytomegalovirus Infections; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2021 |
1 other study(ies) available for atorvastatin and Cytomegalovirus Infections
| Article | Year |
|---|---|
Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Colon; Colonoscopy; Cyclosporine; Cytomegalovirus Infections; Drug Interactions; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrroles; Rhabdomyolysis; Treatment Outcome | 2004 |